[Flucloxacillin in the treatment of respiratory tract infections]. 1972

L Bertoli, and M Martini, and F Fraschini

UI MeSH Term Description Entries
D008297 Male Males
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003023 Cloxacillin A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN. Chloroxacillin,Sodium Cloxacillin,Cloxacillin Sodium,Syntarpen,Tegopen,Cloxacillin, Sodium,Sodium, Cloxacillin
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006219 Halogens A family of nonmetallic, generally electronegative, elements that form group 17 (formerly group VIIa) of the periodic table. Halogen,Group 17 Elements,Elements, Group 17
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L Bertoli, and M Martini, and F Fraschini
May 1978, The New Zealand medical journal,
L Bertoli, and M Martini, and F Fraschini
October 1970, The British journal of clinical practice,
L Bertoli, and M Martini, and F Fraschini
January 1978, Giornale italiano di chemioterapia,
L Bertoli, and M Martini, and F Fraschini
August 1971, The British journal of clinical practice,
L Bertoli, and M Martini, and F Fraschini
January 1993, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
L Bertoli, and M Martini, and F Fraschini
May 1972, The Ohio State medical journal,
L Bertoli, and M Martini, and F Fraschini
January 1969, Le Poumon et le coeur,
L Bertoli, and M Martini, and F Fraschini
October 2000, Ugeskrift for laeger,
L Bertoli, and M Martini, and F Fraschini
December 2000, Ugeskrift for laeger,
Copied contents to your clipboard!